“Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient Response From the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials”, J of Skin, vol. 7, no. 6, p. s252, Nov. 2023, doi: 10.25251/skin.7.supp.252.